Q1 EPS Estimate for Puma Biotechnology Increased by Analyst
Puma Biotechnology, Inc. (NASDAQ:PBYI – Free Report) – Stock analysts at Zacks Research raised their Q1 2026 earnings estimates for shares of Puma Biotechnology in a research report issued to clients and investors on Wednesday, April 30th. Zacks Research analyst R. Department now forecasts that the biopharmaceutical company will post earnings of $0.07 per share […]
